We are live on ! Find out more
RBC

Ronald Blue & Co Portfolio holdings

AUM $3.1B
1-Year Est. Return 12.82%
This Fund
S&P 500
This Quarter Est. Return
-1.21%
1 Year Est. Return
+12.82%
3 Year Est. Return
+2.44%
5 Year Est. Return
10 Year Est. Return
AUM
$2.1B
AUM Growth
+$7.57M
Cap. Flow
+$36.2M
Cap. Flow %
1.72%
Top 10 Hldgs %
86.41%
Holding
379
New
26
Increased
169
Reduced
142
Closed
18

Sector Composition

Rank Sector Weight
1 Healthcare 2.29%
2 Financials 1.86%
3 Energy 1.57%
4 Consumer Staples 1.55%
5 Industrials 1.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NKE icon
101
Nike
NKE
$61.9B
$850K 0.04%
15,724
-150
-0.9% -$7.68K
QCOM icon
102
Qualcomm
QCOM
$155B
$845K 0.04%
13,489
-2,404
-15% -$164K
AFL icon
103
Aflac
AFL
$64.9B
$843K 0.04%
27,092
-662
-2% -$21K
NVO
104
Novo Nordisk
NVO
$208B
$833K 0.04%
30,408
+2,496
+9% +$70.2K
AMZN icon
105
Amazon
AMZN
$2.92T
$821K 0.04%
37,820
-1,300
-3% -$27.2K
MCK icon
106
McKesson
MCK
$100B
$809K 0.04%
3,598
-197
-5% -$45.5K
BIDU icon
107
Baidu
BIDU
$37.7B
$808K 0.04%
4,059
+644
+19% +$132K
BCE icon
108
BCE
BCE
$20.2B
$802K 0.04%
18,875
+1,162
+7% +$51K
SLB icon
109
SLB Ltd
SLB
$73.6B
$802K 0.04%
9,306
+1,402
+18% +$127K
ARMH
110
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$779K 0.04%
15,808
-1,296
-8% -$67.4K
BP icon
111
BP
BP
$116B
$775K 0.04%
23,038
+432
+2% +$15.1K
HDB icon
112
HDFC Bank
HDB
$123B
$758K 0.04%
50,096
+5,576
+13% +$80.9K
AZN icon
113
AstraZeneca
AZN
$263B
$751K 0.04%
11,777
+2,695
+30% +$185K
KMI icon
114
Kinder Morgan
KMI
$71.7B
$750K 0.04%
19,549
+3,069
+19% +$128K
KMB icon
115
Kimberly-Clark
KMB
$36.3B
$748K 0.04%
7,066
+349
+5% +$38K
RAI
116
DELISTED
Reynolds American Inc
RAI
$730K 0.03%
19,550
+2,620
+15% +$98.1K
TXN icon
117
Texas Instruments
TXN
$252B
$720K 0.03%
13,991
+876
+7% +$48.3K
AXP icon
118
American Express
AXP
$227B
$703K 0.03%
9,039
+962
+12% +$76.3K
DD
119
DELISTED
Du Pont De Nemours E I
DD
$692K 0.03%
11,388
-1,320
-10% -$88.9K
ADP icon
120
Automatic Data Processing
ADP
$106B
$690K 0.03%
8,591
-541
-6% -$46.1K
GLD icon
121
SPDR Gold Trust
GLD
$131B
$682K 0.03%
6,064
-3,751
-38% -$429K
VIG icon
122
Vanguard Dividend Appreciation ETF
VIG
$111B
$682K 0.03%
8,675
+4
+0% +$324
MET icon
123
MetLife
MET
$61.9B
$680K 0.03%
13,633
+1,265
+10% +$59.9K
MDT icon
124
Medtronic
MDT
$109B
$676K 0.03%
9,130
+3,318
+57% +$254K
AMLP icon
125
Alerian MLP ETF
AMLP
$13B
$671K 0.03%
+8,629
New +$718K

Similar funds

Ronald Blue & Co's Q2 2015 Portfolio in Review

As of Q2 2015, Ronald Blue & Co held 379 positions worth $2.1B, up 0.36% from $2.1B the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Ronald Blue & Co's Q2 2015 filing shows 26 new, 169 increased, 142 reduced and 18 closed positions. Its largest new stake was Alerian MLP ETF: 8,629 shares worth $671K. The largest sale was iShares MSCI ACWI ex US ETF, an estimated $3.21M.

By sector, the portfolio is most concentrated in Healthcare at 2.3% of assets, up from 2% a quarter earlier, followed by Financials and Energy.

  • Ronald Blue & Co's largest Q2 2015 buy was Alerian MLP ETF: 8,629 shares worth $671K.
  • Ronald Blue & Co added most to Vident US Bond Strategy ETF in Q2 2015, an estimated $13.4M increase.
  • Ronald Blue & Co's biggest Q2 2015 reduction was iShares MSCI ACWI ex US ETF, cutting an estimated $3.21M.
  • Ronald Blue & Co fully exited Royal Bank of Canada in Q2 2015, selling an estimated $1.21M.
  • Ronald Blue & Co's ten largest holdings make up 86% of its $2.1B portfolio in Q2 2015.
  • Ronald Blue & Co opened 26 new positions and closed 18 in Q2 2015.
  • Ronald Blue & Co's portfolio value rose 0.36% quarter-over-quarter to $2.1B.

Based on Ronald Blue & Co's 13F filing for Q2 2015, filed 11 Aug 2015.